跳至主要内容
临床试验/JPRN-jRCT1080224637
JPRN-jRCT1080224637招募中Unknown

Biomarker study auxiliary to a multi-center phase I/II study of cabozantinib and panitumumab combination therapy or cabozantinib monotherapy in patients with MET amplified metastatic colorectal cancer (short title: METBEIGE study)

ational Cancer Center Hospital East0 个研究点目标入组 54 人开始时间: 2019年4月12日最近更新:
适应症

试验速览

阶段
Unknown
状态
招募中
发起方
入组人数
54

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
>= 20age old 至 ot applicable(—)
性别
All

入选标准

  • Patients who are enrolled in the main study and personally provided written consent after adequately explained about the contents of the additional study

排除标准

  • Patients who are determined by the investigator or researchers to be not suitable for participating in the additional study

研究者

发起方
ational Cancer Center Hospital East

相似试验